Pharmarise Holdings Corporation (2796.T)
JPY 563.0
(-2.26%)
JPY 563.0
(-2.26%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 916 Million JPY | -36.3% |
| 2022 | 1.43 Billion JPY | -5.39% |
| 2021 | 1.52 Billion JPY | 21.99% |
| 2020 | 1.24 Billion JPY | 20.5% |
| 2019 | 1.03 Billion JPY | 61.56% |
| 2018 | 640 Million JPY | -45.72% |
| 2017 | 1.17 Billion JPY | 166.74% |
| 2016 | 442 Million JPY | -45.64% |
| 2015 | 813.15 Million JPY | -28.88% |
| 2014 | 1.14 Billion JPY | -27.3% |
| 2013 | 1.57 Billion JPY | 11.4% |
| 2012 | 1.41 Billion JPY | -14.82% |
| 2011 | 1.65 Billion JPY | 10.72% |
| 2010 | 1.49 Billion JPY | 52.29% |
| 2009 | 982.84 Million JPY | 82.06% |
| 2008 | 539.83 Million JPY | 9.26% |
| 2007 | 494.07 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 52 Million JPY | -1.89% |
| 2023 Q2 | 379 Million JPY | 14.5% |
| 2023 Q1 | 331 Million JPY | -38.93% |
| 2023 Q4 | 53 Million JPY | -65.13% |
| 2023 Q3 | 152 Million JPY | -59.89% |
| 2023 FY | 916 Million JPY | -36.3% |
| 2022 Q3 | 323 Million JPY | 43.56% |
| 2022 FY | 1.43 Billion JPY | -5.39% |
| 2022 Q1 | 348 Million JPY | -33.08% |
| 2022 Q2 | 225 Million JPY | -35.34% |
| 2022 Q4 | 542 Million JPY | 67.8% |
| 2021 Q4 | 520 Million JPY | 145.28% |
| 2021 Q3 | 212 Million JPY | -54.99% |
| 2021 Q2 | 471 Million JPY | 48.58% |
| 2021 Q1 | 317 Million JPY | -34.64% |
| 2021 FY | 1.52 Billion JPY | 21.99% |
| 2020 Q2 | 540 Million JPY | 3700.0% |
| 2020 FY | 1.24 Billion JPY | 20.5% |
| 2020 Q4 | 485 Million JPY | 105.51% |
| 2020 Q1 | -15 Million JPY | -105.58% |
| 2020 Q3 | 236 Million JPY | -56.3% |
| 2019 Q2 | 416 Million JPY | 296.19% |
| 2019 Q1 | 105 Million JPY | -70.75% |
| 2019 FY | 1.03 Billion JPY | 61.56% |
| 2019 Q4 | 269 Million JPY | 10.25% |
| 2019 Q3 | 244 Million JPY | -41.35% |
| 2018 Q4 | 359 Million JPY | 235.51% |
| 2018 FY | 640 Million JPY | -45.72% |
| 2018 Q3 | 107 Million JPY | -42.47% |
| 2018 Q2 | 186 Million JPY | 1650.0% |
| 2018 Q1 | -12 Million JPY | -105.43% |
| 2017 FY | 1.17 Billion JPY | 166.74% |
| 2017 Q3 | 374 Million JPY | -13.82% |
| 2017 Q1 | 150 Million JPY | -12.28% |
| 2017 Q2 | 434 Million JPY | 189.33% |
| 2017 Q4 | 221 Million JPY | -40.91% |
| 2016 Q3 | 100 Million JPY | -50.0% |
| 2016 Q1 | -29 Million JPY | -133.39% |
| 2016 Q2 | 200 Million JPY | 789.66% |
| 2016 Q4 | 171 Million JPY | 71.0% |
| 2016 FY | 442 Million JPY | -45.64% |
| 2015 Q2 | 284.31 Million JPY | 31.89% |
| 2015 FY | 813.15 Million JPY | -28.88% |
| 2015 Q1 | 215.56 Million JPY | -42.56% |
| 2015 Q4 | 86.84 Million JPY | -61.64% |
| 2015 Q3 | 226.42 Million JPY | -20.36% |
| 2014 Q3 | 245.62 Million JPY | -34.37% |
| 2014 Q4 | 375.29 Million JPY | 52.79% |
| 2014 Q2 | 374.22 Million JPY | 152.56% |
| 2014 Q1 | 148.17 Million JPY | -68.41% |
| 2014 FY | 1.14 Billion JPY | -27.3% |
| 2013 Q2 | 350.46 Million JPY | -8.38% |
| 2013 Q3 | 370.6 Million JPY | 5.75% |
| 2013 FY | 1.57 Billion JPY | 11.4% |
| 2013 Q4 | 469.09 Million JPY | 26.58% |
| 2013 Q1 | 382.51 Million JPY | -16.8% |
| 2012 Q3 | 312.23 Million JPY | -5.46% |
| 2012 Q2 | 330.25 Million JPY | 6.72% |
| 2012 Q1 | 309.45 Million JPY | -22.21% |
| 2012 FY | 1.41 Billion JPY | -14.82% |
| 2012 Q4 | 459.77 Million JPY | 47.25% |
| 2011 Q4 | 397.81 Million JPY | -9.61% |
| 2011 FY | 1.65 Billion JPY | 10.72% |
| 2011 Q2 | 422.74 Million JPY | 6.59% |
| 2011 Q3 | 440.13 Million JPY | 4.11% |
| 2011 Q1 | 396.6 Million JPY | -24.63% |
| 2010 Q3 | 322.69 Million JPY | -36.09% |
| 2010 Q4 | 526.19 Million JPY | 63.06% |
| 2010 FY | 1.49 Billion JPY | 52.29% |
| 2010 Q1 | 142.96 Million JPY | -63.25% |
| 2010 Q2 | 504.92 Million JPY | 253.19% |
| 2009 Q2 | 241.29 Million JPY | 91.53% |
| 2009 Q3 | 226.52 Million JPY | -6.12% |
| 2009 FY | 982.84 Million JPY | 82.06% |
| 2009 Q1 | 125.98 Million JPY | -31.09% |
| 2009 Q4 | 389.03 Million JPY | 71.74% |
| 2008 Q3 | 204.89 Million JPY | 114.96% |
| 2008 FY | 539.83 Million JPY | 9.26% |
| 2008 Q2 | 95.31 Million JPY | 0.0% |
| 2008 Q4 | 182.82 Million JPY | -10.77% |
| 2007 FY | 494.07 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HEARTSEED INC | -1.45 Billion JPY | 162.756% |
| Cawachi Limited | 7.6 Billion JPY | 87.949% |
| Qol Holdings Co., Ltd. | 8.32 Billion JPY | 88.997% |
| MatsukiyoCocokara & Co. | 75.7 Billion JPY | 98.79% |
| Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 97.881% |
| Create SD Holdings Co., Ltd. | 20.22 Billion JPY | 95.471% |
| NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | 89.983% |
| COSMOS Pharmaceutical Corporation | 31.5 Billion JPY | 97.092% |
| Tsuruha Holdings Inc. | 49.2 Billion JPY | 98.138% |
| Ohki Healthcare Holdings Co.,Ltd. | 2.04 Billion JPY | 55.186% |
| Satudora Holdings Co.,Ltd. | 1.38 Billion JPY | 33.863% |
| Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | 95.067% |
| Medical System Network Co., Ltd. | 3.83 Billion JPY | 76.096% |
| Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | 75.599% |
| Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 97.499% |
| YAKUODO HOLDINGS Co., Ltd. | 5.21 Billion JPY | 82.422% |
| Astena Holdings Co., Ltd. | 1.12 Billion JPY | 18.801% |
| Genky DrugStores Co., Ltd. | 9.01 Billion JPY | 89.84% |
| Ain Holdings Inc. | 20.43 Billion JPY | 95.517% |
| Sundrug Co.,Ltd. | 40.99 Billion JPY | 97.766% |